HUM vs NPCE
Humana Inc (HUM) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the HUM and NPCE stock pages for the full models.
Not investment advice.